Phreesia, Inc.
NYSE:PHRMedical - Healthcare Information Services
+$0.08 today
- Market cap
- $760.99M
- Beta
- 0.88
- P/E (TTM)
- 62.6
- EPS (TTM)
- $0.15
Volume 0.86M
Average 1.97M
PHR Account Payables
Amounts the company owes suppliers for goods and services received.
Phreesia, Inc.NYSE: PHR
Account Payables · Q1 FY2027 · quarter ended Apr 2026
Account payables rises 271.1% from a year ago
Account payables stood at $11.89M at the end of Q1 FY2027, up 271.1% from a year earlier and up 3.6% from the prior quarter. Over 3 fiscal years it compounded at +1.9% a year.
Context
- Account payables amounted to 1.8% of total assets at the end of Q1 FY2027, up 1.0 pp from a year earlier.
- Account payables increased in 1 of the last 3 fiscal years.
- FY2026 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether account payables keeps rising in the next quarterly balance sheet after a +271.1% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Account Payables history
USD · from the balance sheet
- Latest · FY2026
- 11.48M USD
- Year-over-year change
- +104.1%
- 4-year CAGR
- +22.4%
| Period | Period end | Account Payables | YoY change |
|---|---|---|---|
| FY2026 | 2026-01-31 | 11.48M | +104.1% |
| FY2025 | 2025-01-31 | 5.62M | -33.7% |
| FY2024 | 2024-01-31 | 8.48M | -21.7% |
| FY2023 | 2023-01-31 | 10.84M | +111.7% |
| FY2022 | 2022-01-31 | 5.12M | — |
Account Payables vs competitors
How PHR compares with its peers on the latest reported figures
- PHR's Apr 2026 account payables of $11.89M is the 8th highest of the 11 companies compared; the peer median is $30.38M.
- Its year-over-year change of +271.1% is the highest of 11, against a peer median of -1.7%.
- Account payables amounts to 1.8% of total assets for PHR, versus a peer median of 2.5%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $127.24M | +33.8% | +12.8% | 16.1% | |
| Aug 2026 | $77.6M | +1.3% | +1.0% | 2.3% | |
| Mar 2026 | $58.34M | +9.5% | -11.5% | 2.9% | |
| Mar 2026 | $45.2M | -13.2% | +0.2% | 1.6% | |
| Sep 2026 | $36.75M | -7.5% | +29.1% | 10.2% | |
| Jan 2026 | $24.02M | -6.4% | — | 6.3% | |
| Mar 2026 | $14.53M | -4.8% | +3.1% | 0.7% | |
| Apr 2026 | $11.89M | +271.1% | +1.9% | 1.8% | |
| Mar 2026 | $8.1M | +68.1% | +35.8% | 2.7% | |
| Sep 2026 | $7.95M | -13.8% | +6.5% | 1.3% | |
| Mar 2026 | $3.75M | +13.7% | -54.1% | 0.9% | |
| Peer median (excluding PHR) | $30.38M | -1.7% | +3.1% | 2.5% | |
Competitors are the stored peer set for PHR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2022 Jan 2022 | FY2023 Jan 2023 | FY2024 Jan 2024 | FY2025 Jan 2025 | FY2026 Jan 2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | 313.81M | 176.68M | 87.52M | 84.22M | 73.83M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 40.26M | 51.39M | 64.86M | 73.62M | 154.63M |
| Inventory | 1.64M | 1.06M | 768K | 0 | 0 |
| Other Current Assets | 21.74M | 25.94M | 32.48M | 34.13M | 51.39M |
| Total Current Assets | 386.35M | 262.44M | 195.68M | 203.29M | 279.84M |
| Property, Plant & Equipment (Net) | 36.98M | 22.24M | 17.17M | 25.13M | 23.59M |
| Goodwill | 33.62M | 33.74M | 75.85M | 75.85M | 170.06M |
| Intangible Assets | 30.42M | 46.55M | 77.76M | 80.91M | 79.76M |
| Long-term Investments | 2.44M | 0 | 0 | 0 | 0 |
| Tax Assets | 515K | 81K | 0 | 0 | 1.59M |
| Other Non-current Assets | 4.16M | 5.01M | 3.87M | 3.25M | 108.94M |
| Total Non-current Assets | 108.13M | 107.62M | 174.64M | 185.13M | 383.95M |
| Total Assets | 494.48M | 370.06M | 370.33M | 388.42M | 663.79M |
| Account Payables | 5.12M | 10.84M | 8.48M | 5.62M | 11.48M |
| Short-term Debt | 221K | 246K | 1.1M | 1.22M | 2.66M |
| Tax Payables | 2.09M | 1.49M | 3.04M | 2.5M | 0 |
| Deferred Revenue | 16.49M | 17.69M | 24.11M | 32.76M | 49.52M |
| Other Current Liabilities | 26.85M | 32.57M | 53.16M | 844K | 72.29M |
| Total Current Liabilities | 68.43M | 79.04M | 110.12M | 114.02M | 183.24M |
| Long-term Debt | 139K | 2.73M | 2.05M | 719K | 90M |
| Deferred Tax Liabilities | 2.71M | 1.35M | 270K | 484K | 4.5M |
| Deferred Revenue (Non-current) | 65K | 125K | 97K | 119K | 0 |
| Other Non-current Liabilities | (1) | (2.73M) | 2.86M | 185K | 45.62M |
| Total Non-current Liabilities | 8.76M | 3.2M | 8.76M | 9.58M | 143.34M |
| Total Liabilities | 77.2M | 82.24M | 118.88M | 123.61M | 326.58M |
| Common Stock | 521K | 542K | 577K | 601K | 620K |
| Retained Earnings | (429.94M) | (606.08M) | (742.97M) | (801.5M) | (799.19M) |
| Accumulated OCI | 0 | 0 | 0 | (51K) | (382K) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 417.28M | 287.82M | 251.45M | 264.81M | 337.21M |
| Total Debt | 15.8M | 9.18M | 11.98M | 17.8M | 102.45M |
| Net Debt | (298.01M) | (167.5M) | (75.54M) | (66.42M) | 28.62M |
Phreesia, Inc.
NYSE:PHR
Intrinsic Alpha fair value
Locked
Current Price
$12.26
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.